-
Antares announces availability of injectable methotrexate product for arthritis, psoriasis
EWING, N.J. — A new drug for autoimmune diseases from Antares Pharma that the company calls the first of its kind is now available, the drug maker said Wednesday.
Antares announced the availability of Otrexup for rheumatoid arthritis and psoriasis in adults and polyarticular idiopathic arthritis in children. The company said the drug is the first Food and Drug Administration-approved subcutaneous methotrexate product for once-weekly self-administration. Otrexup, which the FDA approved in October, is available with a single-dose auto injector.
-
Reports: Ill. pharmacists hope to dispense medical marijuana
NEW YORK — Pharmacists in Illinois are pushing for the state to let them run medical marijuana dispensaries, according to published reports.
The Chicago Tribune reported that pharmacists are trying to get the state to reclassify marijuana as a Schedule II controlled substance. Currently, the Drug Enforcement Administration classifies it as Schedule I, making it illegal in all circumstances at the federal level; the proposed rescheduling would mean it was legal for medical use, but still tightly regulated, similar to opioid painkillers.